Home » UPC decisions » Luxembourg Court of Appeal » CoA Luxemburg, August 13, 2026, Central Revocation Action, UPC_CoA_884/2025 (appeal from UPC_CFI_231/2024)

CoA Luxemburg, August 13, 2026, Central Revocation Action, UPC_CoA_884/2025 (appeal from UPC_CFI_231/2024)

4 min Reading time

Key takeaways

One situation where added matter may arise is when claimed subject-matter is obtained by importing one or more features from a certain embodiment in the application into a claim, while omitting one or more other features of this embodiment which were presented in combination with the imported feature(s) in the disclosure of this embodiment. This is referred to as an “intermediate generalisation”. This is generally considered to be unallowable if there is a clearly recognisable functional or structural relationship among the omitted feature(s) and the claim features, also referred to ’an extricable link’ between the omitted feature(s) and the claim features.

The technical effect that the invention aims to achieve, and whether an omitted feature contributes thereto, is relevant for the assessment of added matter. It is relevant when considering whether the skilled person would understand from the disclosure of the application as a whole that there is a structural or functional relationship between the omitted feature and the other features of the claimed embodiment or, in other words, when considering whether there is an inextricable link with such other features or, yet differently worded, whether such omitted feature is essential to the invention.

The Court found the claimant’s chosen prior art starting point unsuitable, since reaching the claimed “plug-and-socket from beneath” configuration would require redesigning the entire prior art device, and the combined prior art disclosed the opposite (“top-mounting”) assembly direction.

The defendant’s objection that a claimant’s “essential feature” argument was inadmissible as newly raised on appeal was rejected, since only the substantive test for added matter matters, irrespective of the doctrinal label used.

Division

Court of Appeal (impugned decision issued by the Central Division Paris)

UPC number

UPC_CoA_884/2025 (appeal from UPC_CFI_231/2024)

Type of proceedings

Appeal against a decision dismissing a central revocation action

Parties

Appellant (Claimant at first instance): Sibio Technology Limited

Respondent (Defendant at first instance): Abbott Diabetes Care Inc.

Patent(s)

EP 3 831 283

Jurisdictions

UPC

Body of legislation / Rules

Art. 65(2) UPCA, Art. 69 UPCA, Art. 138(1)(c) EPC, R. 220.1(a) RoP, R. 222.2 RoP


Was the article helpful?


Categories


Tags

Stay in the loop

Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.

* = Required field